Last 12 months
Inside the activity.
0 purchase rows · 28 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 4 |
| Jan 2026 | 0 | 3 |
| Feb 2026 | 0 | 20 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 06, 2025 Filed Jan 7, 2025 22:28 UTC |
SMITH IAN FDirector
|
GrantStock Option (Right to Buy) · Derivative | 22,148 | $0.00 Strike: $4.10 | $0.00 |
DisclosureSEC source: 0000950170-25-003052 · ownership.xml · derivative · entry 3 SMITH IAN F · CIK 0001197032 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,148 Underlying: Common Stock · 22,148 shares Expires 2035-01-06 F3 · derivative.exercise_date: The Smith RSUs (as defined in footnote 4) and this option (together with the Smith RSUs, the "Smith Equity Awards") were granted on January 6, 2025 ("the Grant Date") and vest in equal quarterly installments with the first installment vesting three months from the Grant Date and the final installment vesting date being the date that is 12 months from the Grant Date; provided that in the event of the early termination of the Second Amendment to Executive Chair Agreement between the Issuer and the reporting person (the "Smith Agreement") prior to the expiration of the Term (as defined in the Smith Agreement) and/or a change in control of the Issuer, the Smith Equity Awards shall accelerate in full. Read SEC document |
| January 03, 2025 Filed Jan 7, 2025 22:29 UTC |
Ganot IlanDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 2,994 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-003054 · ownership.xml · derivative · entry 5 Ganot Ilan · CIK 0001727460 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Wife Disclosed balance after: 5,988 Underlying: Common Stock · 2,994 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to common stock on a one-for-one basis. F5 · derivative.exercise_date: On January 3, 2023 (the "Grant Date"), Ms. Ganot was granted 11,975 restricted stock units, vesting in four equal installments on the anniversary of the Grant Date. F5 · derivative.expiration_date: On January 3, 2023 (the "Grant Date"), Ms. Ganot was granted 11,975 restricted stock units, vesting in four equal installments on the anniversary of the Grant Date. Read SEC document |
| January 03, 2025 Filed Jan 7, 2025 22:29 UTC |
Ganot IlanDirector
|
Exercise / conversionCommon Stock | 2,994 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-003054 · ownership.xml · nonDerivative · entry 1 Ganot Ilan · CIK 0001727460 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Wife Disclosed balance after: 12,501 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to common stock on a one-for-one basis. Read SEC document |
| January 03, 2025 Filed Jan 7, 2025 22:28 UTC |
SMITH IAN FDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 3,255 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-003052 · ownership.xml · derivative · entry 2 SMITH IAN F · CIK 0001197032 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,255 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to common stock on a one-for-one basis. F2 · derivative.exercise_date: The restricted stock units were granted on January 3, 2024 and vested in equal quarterly installments beginning three months from the date of grant, with the final installment vesting 12 months from the date of grant. F2 · derivative.expiration_date: The restricted stock units were granted on January 3, 2024 and vested in equal quarterly installments beginning three months from the date of grant, with the final installment vesting 12 months from the date of grant. Read SEC document |
| January 03, 2025 Filed Jan 7, 2025 22:28 UTC |
SMITH IAN FDirector
|
Exercise / conversionCommon Stock | 3,255 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-003052 · ownership.xml · nonDerivative · entry 1 SMITH IAN F · CIK 0001197032 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,972 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to common stock on a one-for-one basis. Read SEC document |
| December 03, 2024 Filed Dec 4, 2024 22:34 UTC |
Hanrahan JessieChief Regulatory Officer
|
SaleCommon Stock | 4,610 | $5.60 | $25,822.45 |
DisclosureSEC source: 0000950170-24-133369 · ownership.xml · nonDerivative · entry 2 Hanrahan Jessie · CIK 0001954826 · Chief Regulatory Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,235 F2 · shares: This sale was made to cover withholding taxes following the vesting of the previously granted RSUs. The sale does not represent a discretionary trade made by Dr. Hanrahan. Read SEC document |
| December 03, 2024 Filed Dec 4, 2024 22:27 UTC |
Cumbo AlexanderDirector · President and CEO
|
SaleCommon Stock | 11,114 | $5.60 | $62,236.18 |
DisclosureSEC source: 0000950170-24-133360 · ownership.xml · nonDerivative · entry 2 Cumbo Alexander · CIK 0001685994 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,484 F3 · shares: This sale was made to cover withholding taxes following the vesting of the previously granted RSUs. The sale does not represent a discretionary trade made by Mr. Cumbo. Read SEC document |
| December 03, 2024 Filed Dec 4, 2024 22:04 UTC |
Howton David TChief Operating Officer
|
SaleCommon Stock | 5,072 | $5.60 | $28,396.10 |
DisclosureSEC source: 0000950170-24-133340 · ownership.xml · nonDerivative · entry 2 Howton David T · CIK 0001529297 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,663 F2 · shares: This sale was made to cover withholding taxes following the vesting of the previously granted RSUs. The sale does not represent a discretionary trade made by Mr. Howton. Read SEC document |
| December 03, 2024 Filed Dec 4, 2024 21:42 UTC |
Herzich PaulChief Technology Officer
|
SaleCommon Stock | 2,777 | $5.60 | $15,550.64 |
DisclosureSEC source: 0000950170-24-133317 · ownership.xml · nonDerivative · entry 2 Herzich Paul · CIK 0001954991 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,182 F3 · shares: This sale was made to cover withholding taxes following the vesting of the previously granted RSUs. The sale does not represent a discretionary trade made by Dr. Herzich. Read SEC document |
| December 02, 2024 Filed Dec 4, 2024 22:34 UTC |
Hanrahan JessieChief Regulatory Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 11,862 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-133369 · ownership.xml · derivative · entry 3 Hanrahan Jessie · CIK 0001954826 · Chief Regulatory Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,725 Underlying: Common Stock · 11,862 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the "RSUs"). F3 · derivative.exercise_date: The RSUs were granted on December 2, 2022 (the "Grant Date") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary. F3 · derivative.expiration_date: The RSUs were granted on December 2, 2022 (the "Grant Date") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary. Read SEC document |
| December 02, 2024 Filed Dec 4, 2024 22:34 UTC |
Hanrahan JessieChief Regulatory Officer
|
Exercise / conversionCommon Stock | 11,862 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-133369 · ownership.xml · nonDerivative · entry 1 Hanrahan Jessie · CIK 0001954826 · Chief Regulatory Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,845 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the "RSUs"). Read SEC document |
| December 02, 2024 Filed Dec 4, 2024 22:27 UTC |
Cumbo AlexanderDirector · President and CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 28,612 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-133360 · ownership.xml · derivative · entry 3 Cumbo Alexander · CIK 0001685994 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,225 Underlying: Common Stock · 28,612 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the "RSUs"). F4 · derivative.exercise_date: The RSUs were granted on December 2, 2022 (the "Grant Date") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary. F4 · derivative.expiration_date: The RSUs were granted on December 2, 2022 (the "Grant Date") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary. Read SEC document |
| December 02, 2024 Filed Dec 4, 2024 22:27 UTC |
Cumbo AlexanderDirector · President and CEO
|
Exercise / conversionCommon Stock | 28,612 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-133360 · ownership.xml · nonDerivative · entry 1 Cumbo Alexander · CIK 0001685994 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,598 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the "RSUs"). F2 · balance_after: Includes 3,547 shares of common stock acquired under the Solid Biosciences Inc. Employee Stock Purchase Plan on May 31, 2024. Read SEC document |
| December 02, 2024 Filed Dec 4, 2024 22:04 UTC |
Howton David TChief Operating Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 13,051 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-133340 · ownership.xml · derivative · entry 3 Howton David T · CIK 0001529297 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,103 Underlying: Common Stock · 13,051 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the "RSUs"). F3 · derivative.exercise_date: The RSUs were granted on December 2, 2022 (the "Grant Date") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary. F3 · derivative.expiration_date: The RSUs were granted on December 2, 2022 (the "Grant Date") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary. Read SEC document |
| December 02, 2024 Filed Dec 4, 2024 22:04 UTC |
Howton David TChief Operating Officer
|
Exercise / conversionCommon Stock | 13,051 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-133340 · ownership.xml · nonDerivative · entry 1 Howton David T · CIK 0001529297 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,735 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the "RSUs"). Read SEC document |
| December 02, 2024 Filed Dec 4, 2024 21:42 UTC |
Herzich PaulChief Technology Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 7,239 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-133317 · ownership.xml · derivative · entry 3 Herzich Paul · CIK 0001954991 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,478 Underlying: Common Stock · 7,239 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the "RSUs"). F4 · derivative.exercise_date: The RSUs were granted on December 2, 2022 (the "Grant Date") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary. F4 · derivative.expiration_date: The RSUs were granted on December 2, 2022 (the "Grant Date") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary. Read SEC document |
| December 02, 2024 Filed Dec 4, 2024 21:42 UTC |
Herzich PaulChief Technology Officer
|
Exercise / conversionCommon Stock | 7,239 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-133317 · ownership.xml · nonDerivative · entry 1 Herzich Paul · CIK 0001954991 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,959 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the "RSUs"). F2 · balance_after: Includes 1,698 shares of common stock acquired under the Solid Biosciences Inc. Employee Stock Purchase Plan on May 31, 2024. Read SEC document |
| October 21, 2024 Filed Oct 22, 2024 20:05 UTC |
Brooks GabrielChief Medical Officer
|
SaleCommon Stock | 2,923 | $6.50 | $18,999.50 |
DisclosureSEC source: 0000950170-24-116246 · ownership.xml · nonDerivative · entry 2 Brooks Gabriel · CIK 0001997809 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,979 F3 · shares: This sale was made to cover withholding taxes following the vesting of the previously granted RSUs. Read SEC document |
| October 18, 2024 Filed Oct 22, 2024 20:05 UTC |
Brooks GabrielChief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 9,750 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-116246 · ownership.xml · derivative · entry 3 Brooks Gabriel · CIK 0001997809 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,250 Underlying: Common Stock · 9,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis. F4 · derivative.exercise_date: The RSUs were granted on October 18, 2023 (the "Grant Date") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary. F4 · derivative.expiration_date: The RSUs were granted on October 18, 2023 (the "Grant Date") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary. Read SEC document |
| October 18, 2024 Filed Oct 22, 2024 20:05 UTC |
Brooks GabrielChief Medical Officer
|
Exercise / conversionCommon Stock | 9,750 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-116246 · ownership.xml · nonDerivative · entry 1 Brooks Gabriel · CIK 0001997809 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,902 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis. F2 · balance_after: Includes 4,152 shares of common stock acquired under the Solid Biosciences Inc. Employee Stock Purchase Plan on May 31, 2024. Read SEC document |
| October 03, 2024 Filed Oct 4, 2024 20:05 UTC |
SMITH IAN FDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 3,255 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-112898 · ownership.xml · derivative · entry 2 SMITH IAN F · CIK 0001197032 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,255 Underlying: Common Stock · 3,255 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: The restricted stock units were granted on January 3, 2024 (the "Grant Date") and vest in equal quarterly installments beginning three months from the Grant Date, with the final installment vesting the date that is 12 months from the Grant Date; provided that in the event of early termination of the Second Amendment to the Executive Chair Agreement between the Issuer and the reporting person (the "Smith Agreement") prior to the expiration of the Term (as defined in the Smith Agreement) and/or a change in control of the Issuer, the restricted stock units shall accelerate in full. F2 · derivative.expiration_date: The restricted stock units were granted on January 3, 2024 (the "Grant Date") and vest in equal quarterly installments beginning three months from the Grant Date, with the final installment vesting the date that is 12 months from the Grant Date; provided that in the event of early termination of the Second Amendment to the Executive Chair Agreement between the Issuer and the reporting person (the "Smith Agreement") prior to the expiration of the Term (as defined in the Smith Agreement) and/or a change in control of the Issuer, the restricted stock units shall accelerate in full. Read SEC document |
| October 03, 2024 Filed Oct 4, 2024 20:05 UTC |
SMITH IAN FDirector
|
Exercise / conversionCommon Stock | 3,255 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-112898 · ownership.xml · nonDerivative · entry 1 SMITH IAN F · CIK 0001197032 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 109,717 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| July 03, 2024 Filed Jul 5, 2024 20:05 UTC |
SMITH IAN FDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 3,255 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-081866 · ownership.xml · derivative · entry 2 SMITH IAN F · CIK 0001197032 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,510 Underlying: Common Stock · 3,255 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: The restricted stock units were granted on January 3, 2024 (the "Grant Date") and vest in equal quarterly installments beginning three months from the Grant Date, with the final installment vesting the date that is 12 months from the Grant Date; provided that in the event of early termination of the Second Amendment to the Executive Chair Agreement between the Issuer and the reporting person (the "Smith Agreement") prior to the expiration of the Term (as defined in the Smith Agreement) and/or a change in control of the Issuer, the restricted stock units shall accelerate in full. F2 · derivative.expiration_date: The restricted stock units were granted on January 3, 2024 (the "Grant Date") and vest in equal quarterly installments beginning three months from the Grant Date, with the final installment vesting the date that is 12 months from the Grant Date; provided that in the event of early termination of the Second Amendment to the Executive Chair Agreement between the Issuer and the reporting person (the "Smith Agreement") prior to the expiration of the Term (as defined in the Smith Agreement) and/or a change in control of the Issuer, the restricted stock units shall accelerate in full. Read SEC document |
| July 03, 2024 Filed Jul 5, 2024 20:05 UTC |
SMITH IAN FDirector
|
Exercise / conversionCommon Stock | 3,255 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-081866 · ownership.xml · nonDerivative · entry 1 SMITH IAN F · CIK 0001197032 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 106,462 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| June 11, 2024 Filed Jun 13, 2024 20:05 UTC |
Ganot IlanDirector
|
GrantDirector Stock Option (Right to Buy) · Derivative | 34,400 | $0.00 Strike: $7.51 | $0.00 |
DisclosureSEC source: 0000950170-24-072992 · ownership.xml · derivative · entry 1 Ganot Ilan · CIK 0001727460 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,400 Underlying: Common Stock · 34,400 shares Expires 2034-06-11 F1 · derivative.exercise_date: This option was granted on June 11, 2024 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events. Read SEC document |
| June 11, 2024 Filed Jun 13, 2024 20:13 UTC |
Keresty GeorgiaDirector
|
GrantDirector Stock Option (Right to Buy) · Derivative | 34,400 | $0.00 Strike: $7.51 | $0.00 |
DisclosureSEC source: 0000950170-24-073013 · ownership.xml · derivative · entry 1 Keresty Georgia · CIK 0001773532 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,400 Underlying: Common Stock · 34,400 shares Expires 2034-06-11 F1 · derivative.exercise_date: This option was granted on June 11, 2024 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events. Read SEC document |
| June 11, 2024 Filed Jun 13, 2024 20:11 UTC |
SMITH IAN FDirector
|
GrantDirector Stock Option (Right to Buy) · Derivative | 34,400 | $0.00 Strike: $7.51 | $0.00 |
DisclosureSEC source: 0000950170-24-073006 · ownership.xml · derivative · entry 1 SMITH IAN F · CIK 0001197032 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,400 Underlying: Common Stock · 34,400 shares Expires 2034-06-11 F1 · derivative.exercise_date: This option was granted on June 11, 2024 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events. Read SEC document |
| June 11, 2024 Filed Jun 13, 2024 20:10 UTC |
Sullivan Lynne MarieDirector
|
GrantDirector Stock Option (Right to Buy) · Derivative | 34,400 | $0.00 Strike: $7.51 | $0.00 |
DisclosureSEC source: 0000950170-24-073003 · ownership.xml · derivative · entry 1 Sullivan Lynne Marie · CIK 0001727640 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,400 Underlying: Common Stock · 34,400 shares Expires 2034-06-11 F1 · derivative.exercise_date: This option was granted on June 11, 2024 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events. Read SEC document |
| June 11, 2024 Filed Jun 13, 2024 20:10 UTC |
Freed Martin IDirector
|
GrantDirector Stock Option (Right to Buy) · Derivative | 34,400 | $0.00 Strike: $7.51 | $0.00 |
DisclosureSEC source: 0000950170-24-073000 · ownership.xml · derivative · entry 1 Freed Martin I · CIK 0001676653 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,400 Underlying: Common Stock · 34,400 shares Expires 2034-06-11 F1 · derivative.exercise_date: This option was granted on June 11, 2024 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events. Read SEC document |
| June 11, 2024 Filed Jun 13, 2024 20:08 UTC |
Nagendran SukumarDirector
|
GrantDirector Stock Option (Right to Buy) · Derivative | 34,400 | $0.00 Strike: $7.51 | $0.00 |
DisclosureSEC source: 0000950170-24-072998 · ownership.xml · derivative · entry 1 Nagendran Sukumar · CIK 0001665124 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,400 Underlying: Common Stock · 34,400 shares Expires 2034-06-11 F1 · derivative.exercise_date: This option was granted on June 11, 2024 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events. Read SEC document |
| June 11, 2024 Filed Jun 13, 2024 20:06 UTC |
Kahn ClareDirector
|
GrantDirector Stock Option (Right to Buy) · Derivative | 34,400 | $0.00 Strike: $7.51 | $0.00 |
DisclosureSEC source: 0000950170-24-072996 · ownership.xml · derivative · entry 1 Kahn Clare · CIK 0001849236 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,400 Underlying: Common Stock · 34,400 shares Expires 2034-06-11 F1 · derivative.exercise_date: This option was granted on June 11, 2024 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events. Read SEC document |
| June 11, 2024 Filed Nov 19, 2024 21:20 UTC |
PERCEPTIVE ADVISORS LLCDirector · 10% owner
PERCEPTIVE LIFE SCIENCES MASTER FUND LTDDirector · 10% owner
EDELMAN JOSEPHDirector · 10% owner
|
GrantDirector Stock Option (Right to Buy) · Derivative | 34,400 | $0.00 Strike: $7.51 | $0.00 |
DisclosureSEC source: 0001062993-24-019352 · form4.xml · derivative · entry 1 PERCEPTIVE ADVISORS LLC · CIK 0001224962 · Director · 10% owner PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · Director · 10% owner EDELMAN JOSEPH · CIK 0001164426 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 34,400 Underlying: Common Stock · 34,400 shares Expires 2034-06-11 F1 · derivative.exercise_date: This option was granted on June 11, 2024 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events. F2 · ownership.nature: Consists of options to purchase shares of the Issuer's common stock awarded to Adam Stone in connection with his role as a member of the Issuer's Board of Directors. Mr. Stone is the Chief Investment Officer of Perceptive Advisors, LLC (the "Advisor"). The Advisor may be deemed to have an indirect pecuniary interest in the options to purchase common stock of the Issuer reported herein because the Advisor has the right to receive the director compensation provided in respect of Mr. Stone's board service through a partial management fee offset. F3 · ownership.nature: Joseph Edelman is the managing member of the Advisor. Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| June 11, 2024 Filed Nov 19, 2024 21:20 UTC |
Stone Adam LeoDirector
|
GrantDirector Stock Option (Right to Buy) · Derivative | 34,400 | $0.00 Strike: $7.51 | $0.00 |
DisclosureSEC source: 0001062993-24-019353 · form4.xml · derivative · entry 1 Stone Adam Leo · CIK 0001727440 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,400 Underlying: Common Stock · 34,400 shares Expires 2034-06-11 F1 · derivative.exercise_date: This option was granted on June 11, 2024 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events. Read SEC document |
| June 07, 2024 Filed Jun 11, 2024 18:15 UTC |
Kahn ClareDirector
|
PurchaseCommon Stock | 1,100 | $7.67 | $8,441.62 |
DisclosureSEC source: 0000950170-24-071765 · ownership.xml · nonDerivative · entry 1 Kahn Clare · CIK 0001849236 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,100 Read SEC document |
| May 02, 2024 Filed May 6, 2024 22:48 UTC |
Ganot IlanDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 1,553 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-053774 · ownership.xml · derivative · entry 5 Ganot Ilan · CIK 0001727460 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Wife Disclosed balance after: 0 Underlying: Common Stock · 1,553 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F5 · derivative.exercise_date: The restricted stock units were granted on May 2, 2022 and vested in two equal installments on May 2, 2023 and May 2, 2024. F5 · derivative.expiration_date: The restricted stock units were granted on May 2, 2022 and vested in two equal installments on May 2, 2023 and May 2, 2024. Read SEC document |
| May 02, 2024 Filed May 6, 2024 22:48 UTC |
Ganot IlanDirector
|
SaleCommon Stock | 462 | $10.33 | $4,772.46 |
DisclosureSEC source: 0000950170-24-053774 · ownership.xml · nonDerivative · entry 2 Ganot Ilan · CIK 0001727460 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Wife Disclosed balance after: 9,507 F2 · shares: This sale was made to cover withholding taxes following the vesting of previously granted restricted stock units. This sale does not represent a discretionary trade by Ms. Ganot. Read SEC document |
| May 02, 2024 Filed May 6, 2024 22:48 UTC |
Ganot IlanDirector
|
Exercise / conversionCommon Stock | 1,553 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-053774 · ownership.xml · nonDerivative · entry 1 Ganot Ilan · CIK 0001727460 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Wife Disclosed balance after: 9,969 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| April 03, 2024 Filed Apr 5, 2024 20:45 UTC |
SMITH IAN FDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 3,256 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-042322 · ownership.xml · derivative · entry 2 SMITH IAN F · CIK 0001197032 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,765 Underlying: Common Stock · 3,256 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: The restricted stock units were granted on January 3, 2024 (the "Grant Date") and vest in equal quarterly installments beginning three months from the Grant Date, with the final installment vesting the date that is 12 months from the Grant Date; provided that in the event of early termination of the Second Amendment to the Executive Chair Agreement between the Issuer and the reporting person (the "Smith Agreement") prior to the expiration of the Term (as defined in the Smith Agreement) and/or a change in control of the Issuer, the restricted stock units shall accelerate in full. F2 · derivative.expiration_date: The restricted stock units were granted on January 3, 2024 (the "Grant Date") and vest in equal quarterly installments beginning three months from the Grant Date, with the final installment vesting the date that is 12 months from the Grant Date; provided that in the event of early termination of the Second Amendment to the Executive Chair Agreement between the Issuer and the reporting person (the "Smith Agreement") prior to the expiration of the Term (as defined in the Smith Agreement) and/or a change in control of the Issuer, the restricted stock units shall accelerate in full. Read SEC document |
| April 03, 2024 Filed Apr 5, 2024 20:45 UTC |
SMITH IAN FDirector
|
Exercise / conversionCommon Stock | 3,256 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-042322 · ownership.xml · nonDerivative · entry 1 SMITH IAN F · CIK 0001197032 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 103,207 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| February 13, 2024 Filed Feb 16, 2024 15:50 UTC |
Ganot IlanDirector
|
GrantRestricted Stock Units · Derivative | 19,444 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-016180 · ownership.xml · derivative · entry 1 Ganot Ilan · CIK 0001727460 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Wife Disclosed balance after: 19,444 Underlying: Common Stock · 19,444 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock (the "RSUs"). F2 · derivative.exercise_date: The RSUs were granted on the February 13, 2024 and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary. F2 · derivative.expiration_date: The RSUs were granted on the February 13, 2024 and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary. Read SEC document |
| February 13, 2024 Filed Feb 16, 2024 17:03 UTC |
Hanrahan JessieChief Regulatory Officer
|
GrantRestricted Stock Units · Derivative | 32,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-016220 · ownership.xml · derivative · entry 2 Hanrahan Jessie · CIK 0001954826 · Chief Regulatory Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,500 Underlying: Common Stock · 32,500 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock (the "RSUs"). F3 · derivative.exercise_date: The RSUs were granted on the Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary. F3 · derivative.expiration_date: The RSUs were granted on the Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary. Read SEC document |
| February 13, 2024 Filed Feb 16, 2024 17:03 UTC |
Hanrahan JessieChief Regulatory Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 65,000 | $0.00 Strike: $7.85 | $0.00 |
DisclosureSEC source: 0000950170-24-016220 · ownership.xml · derivative · entry 1 Hanrahan Jessie · CIK 0001954826 · Chief Regulatory Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,000 Underlying: Common Stock · 65,000 shares Expires 2034-02-13 F1 · derivative.exercise_date: This option was granted on February 13, 2024 (the "Grant Date") and vests over four years, with 25% of the original number of shares vesting on the first anniversary of the Grant Date and 2.0833% of the original number of shares monthly thereafter until the fourth such anniversary. Read SEC document |
| February 13, 2024 Filed Feb 16, 2024 17:01 UTC |
Cumbo AlexanderDirector · President and CEO
|
GrantRestricted Stock Units · Derivative | 120,125 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-016219 · ownership.xml · derivative · entry 2 Cumbo Alexander · CIK 0001685994 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 120,125 Underlying: Common Stock · 120,125 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock (the "RSUs"). F3 · derivative.exercise_date: The RSUs were granted on the Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary. F3 · derivative.expiration_date: The RSUs were granted on the Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary. Read SEC document |
| February 13, 2024 Filed Feb 16, 2024 17:01 UTC |
Cumbo AlexanderDirector · President and CEO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 240,250 | $0.00 Strike: $7.85 | $0.00 |
DisclosureSEC source: 0000950170-24-016219 · ownership.xml · derivative · entry 1 Cumbo Alexander · CIK 0001685994 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 240,250 Underlying: Common Stock · 240,250 shares Expires 2034-02-13 F1 · derivative.exercise_date: This option was granted on February 13, 2024 (the "Grant Date") and vests over four years, with 25% of the original number of shares vesting on the first anniversary of the Grant Date and 2.0833% of the original number of shares monthly thereafter until the fourth such anniversary. Read SEC document |
| February 13, 2024 Filed Feb 16, 2024 16:56 UTC |
Brooks GabrielChief Medical Officer
|
GrantRestricted Stock Units · Derivative | 43,750 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-016216 · ownership.xml · derivative · entry 2 Brooks Gabriel · CIK 0001997809 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,750 Underlying: Common Stock · 43,750 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock (the "RSUs"). F3 · derivative.exercise_date: The RSUs were granted on the Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary. F3 · derivative.expiration_date: The RSUs were granted on the Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary. Read SEC document |
| February 13, 2024 Filed Feb 16, 2024 16:56 UTC |
Brooks GabrielChief Medical Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 87,500 | $0.00 Strike: $7.85 | $0.00 |
DisclosureSEC source: 0000950170-24-016216 · ownership.xml · derivative · entry 1 Brooks Gabriel · CIK 0001997809 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,500 Underlying: Common Stock · 87,500 shares Expires 2034-02-13 F1 · derivative.exercise_date: This option was granted on February 13, 2024 (the "Grant Date") and vests over four years, with 25% of the original number of shares vesting on the first anniversary of the Grant Date and 2.0833% of the original number of shares monthly thereafter until the fourth such anniversary. Read SEC document |
| February 13, 2024 Filed Feb 16, 2024 16:45 UTC |
Tan KevinCFO & Treasurer
|
GrantRestricted Stock Units · Derivative | 42,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-016213 · ownership.xml · derivative · entry 2 Tan Kevin · CIK 0001884056 · CFO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,500 Underlying: Common Stock · 42,500 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock (the "RSUs"). F3 · derivative.exercise_date: The RSUs were granted on the Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary. F3 · derivative.expiration_date: The RSUs were granted on the Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary. Read SEC document |
| February 13, 2024 Filed Feb 16, 2024 16:45 UTC |
Tan KevinCFO & Treasurer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 85,000 | $0.00 Strike: $7.85 | $0.00 |
DisclosureSEC source: 0000950170-24-016213 · ownership.xml · derivative · entry 1 Tan Kevin · CIK 0001884056 · CFO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,000 Underlying: Common Stock · 85,000 shares Expires 2034-02-13 F1 · derivative.exercise_date: This option was granted on February 13, 2024 (the "Grant Date") and vests over four years, with 25% of the original number of shares vesting on the first anniversary of the Grant Date and 2.0833% of the original number of shares monthly thereafter until the fourth such anniversary. Read SEC document |
| February 13, 2024 Filed Feb 16, 2024 16:28 UTC |
Howton David TChief Operating Officer
|
GrantRestricted Stock Units · Derivative | 58,750 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-016193 · ownership.xml · derivative · entry 2 Howton David T · CIK 0001529297 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,750 Underlying: Common Stock · 58,750 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock (the "RSUs"). F3 · derivative.exercise_date: The RSUs were granted on the Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary. F3 · derivative.expiration_date: The RSUs were granted on the Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary. Read SEC document |
| February 13, 2024 Filed Feb 16, 2024 16:28 UTC |
Howton David TChief Operating Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 117,500 | $0.00 Strike: $7.85 | $0.00 |
DisclosureSEC source: 0000950170-24-016193 · ownership.xml · derivative · entry 1 Howton David T · CIK 0001529297 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 117,500 Underlying: Common Stock · 117,500 shares Expires 2034-02-13 F1 · derivative.exercise_date: This option was granted on February 13, 2024 (the "Grant Date") and vests over four years, with 25% of the original number of shares vesting on the first anniversary of the Grant Date and 2.0833% of the original number of shares monthly thereafter until the fourth such anniversary. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.